EXTRANODAL LYMPHOMA IN THE CAT Prognostic factors and treatment options

被引:22
作者
Moore, Antony [1 ]
机构
[1] Vet Oncol Consultants Pty Ltd, Wauchope, NSW 2446, Australia
关键词
CENTRAL-NERVOUS-SYSTEM; FELINE LYMPHOMA; MALIGNANT-LYMPHOMA; LOCALIZED LYMPHOMA; NASAL LYMPHOMA; RENAL LYMPHOMA; LYMPHOSARCOMA; CHEMOTHERAPY; TUMOR; THERAPY;
D O I
10.1177/1098612X13483236
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Practical relevance: The majority of feline lymphoma is extranodal. While the gastrointestinal (GI) tract is the most commonly affected site, non-GI extranodal lymphomas, which are the focus of this review, account for a large proportion of lymphomas in cats. This article discusses prognostic factors for the most common of these extranodal lymphomas, both in general terms and specifically for individual sites. Clinical challenges: Prognostic factors remain poorly defined for feline lymphoma. Many cats with extranodal lymphoma have stage I disease at an accessible site. A major question for patients with apparently localised extranodal lymphoma is whether the tumour can be treated with localised therapy alone or requires systemic treatment as well. Again there is often no specific information available for a particular site, such as a localised intramuscular lymphoma. Instead, reliance must be placed on careful patient staging, particularly if local therapy alone is planned. Evidence base: Until such time as further studies looking at stage, anatomic site, histological grade and immunophenotype are available to assist treatment decision making for an individual cat with extranodal lymphoma, it seems reasonable to draw inferences from other common extranodal sites for which more specific information exists, such as nasal lymphoma.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 61 条
[11]   Evaluation of lomustine as a rescue agent for cats with resistant lymphoma [J].
Dutelle, Autumn L. ;
Bulman-Fleming, Julie C. ;
Lewis, Craig A. ;
Rosenberg, Mona P. .
JOURNAL OF FELINE MEDICINE AND SURGERY, 2012, 14 (10) :694-700
[12]   RADIOTHERAPY WITH AND WITHOUT CHEMOTHERAPY FOR LOCALIZED LYMPHOMA IN 10 CATS [J].
ELMSLIE, RE ;
OGILVIE, GK ;
GILLETTE, EL ;
MCCHESNEYGILLETTE, S .
VETERINARY RADIOLOGY, 1991, 32 (06) :277-280
[13]   Clinical and anatomical features of lymphosarcoma in 118 cats [J].
Gabor, LJ ;
Malik, R ;
Canfield, PJ .
AUSTRALIAN VETERINARY JOURNAL, 1998, 76 (11) :725-732
[14]   Feline immunodeficiency virus status of Australian cats with lymphosarcoma [J].
Gabor, LJ ;
Love, DN ;
Malik, R ;
Canfield, PJ .
AUSTRALIAN VETERINARY JOURNAL, 2001, 79 (08) :540-545
[15]   Immunophenotypic and histological characterisation of 109 cases of feline lymphosarcoma [J].
Gabor, LJ ;
Canfield, PJ ;
Malik, R .
AUSTRALIAN VETERINARY JOURNAL, 1999, 77 (07) :436-441
[16]   Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats [J].
Hadden, A. G. ;
Cotter, S. M. ;
Rand, W. ;
Moore, A. S. ;
Davis, R. M. ;
Morrissey, P. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (01) :153-157
[17]   Survival Analysis of 97 Cats with Nasal Lymphoma: A Multi-Institutional Retrospective Study (1986-2006) [J].
Haney, S. M. ;
Beaver, L. ;
Turrel, J. ;
Clifford, C. A. ;
Klein, M. K. ;
Crawford, S. ;
Poulson, J. M. ;
Azuma, C. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (02) :287-294
[18]  
HARDY WD, 1981, J AM ANIM HOSP ASSOC, V17, P921
[19]   Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005) [J].
Kiselow, Michael A. ;
Rassnick, Kenneth M. ;
McDonough, Sean P. ;
Goldstein, Richard E. ;
Simpson, Kenneth W. ;
Weinkle, Tristan K. ;
Erb, Hollis N. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 232 (03) :405-410
[20]  
Kristal O, 1998, P 18 ANN VET CANC SO, P25